One-Year Results with Extended-Release Tacrolimus/MMF, Tacrolimus/MMF and Cyclosporine/MMF in De Novo Kidney Transplant Recipients
Open Access
- 11 January 2007
- journal article
- research article
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 7 (3), 595-608
- https://doi.org/10.1111/j.1600-6143.2007.01661.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Therapeutic Drug Monitoring of Mycophenolate Mofetil in TransplantationTherapeutic Drug Monitoring, 2006
- Explaining Variability in Mycophenolic Acid Exposure to Optimize Mycophenolate Mofetil DosingJournal of the American Society of Nephrology, 2006
- Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial dataBMJ, 2005
- New Onset Diabetes Mellitus in Patients Receiving Calcineurin Inhibitors: A Systematic Review and Meta-AnalysisAmerican Journal of Transplantation, 2004
- Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three yearsTransplantation, 2003
- Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months1Transplantation, 2003
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999
- IMMUNOSUPPRESSIVE THERAPY IN HIGH-RISK TRANSPLANT PATIENTSTransplantation, 1997
- A COMPARISON OF TACROLIMUS (FK506) AND CYCLOSPORINE FOR IMMUNOSUPPRESSION AFTER CADAVERIC RENAL TRANSPLANTATION1Transplantation, 1997
- INTRA‐ AND INTERINDIVIDUAL VARIATION IN THE PHARMACOKINETICS OF TACROLIMUS (FK506) IN KIDNEY TRANSPLANT RECIPIENTS—IMPORTANCE OF TROUGH LEVEL AS A PRACTICAL INDICATORInternational Journal of Urology, 1995